Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 10:33AM ET
11.61
Dollar change
-0.25
Percentage change
-2.11
%
IndexRUT P/E- EPS (ttm)-0.52 Insider Own3.01% Shs Outstand293.59M Perf Week-0.68%
Market Cap3.43B Forward P/E29.28 EPS next Y0.40 Insider Trans-5.67% Shs Float286.50M Perf Month-10.35%
Income-151.58M PEG- EPS next Q-0.06 Inst Own106.62% Short Float11.31% Perf Quarter-19.54%
Sales399.36M P/S8.59 EPS this Y100.97% Inst Trans-4.34% Short Ratio10.34 Perf Half Y-9.86%
Book/sh0.55 P/B21.28 EPS next Y7948.83% ROA-20.18% Short Interest32.40M Perf Year3.57%
Cash/sh0.97 P/C11.98 EPS next 5Y- ROE-107.04% 52W Range9.70 - 14.57 Perf YTD-18.18%
Dividend Est.- P/FCF- EPS past 5Y22.84% ROI-25.39% 52W High-20.32% Beta0.75
Dividend TTM- Quick Ratio2.52 Sales past 5Y37.81% Gross Margin88.68% 52W Low19.69% ATR (14)0.46
Dividend Ex-Date- Current Ratio2.88 EPS Y/Y TTM37.05% Oper. Margin-18.40% RSI (14)40.62 Volatility3.68% 4.26%
Employees517 Debt/Eq2.78 Sales Y/Y TTM21.30% Profit Margin-37.96% Recom1.55 Target Price19.00
Option/ShortYes / Yes LT Debt/Eq2.73 EPS Q/Q41.97% Payout- Rel Volume0.47 Prev Close11.86
Sales Surprise0.64% EPS Surprise-90.31% Sales Q/Q30.63% EarningsFeb 28 BMO Avg Volume3.13M Price11.61
SMA20-4.18% SMA50-8.30% SMA200-6.15% Trades Volume300,377 Change-2.11%
Date Action Analyst Rating Change Price Target Change
Dec-19-23Upgrade Morgan Stanley Equal-Weight → Overweight $15 → $20
Sep-09-22Initiated Morgan Stanley Equal-Weight $14
Apr-13-22Resumed Goldman Neutral $11
Jan-14-22Upgrade SVB Leerink Mkt Perform → Outperform $12 → $16
Nov-15-21Upgrade Stifel Hold → Buy $12 → $16
Sep-30-21Upgrade JP Morgan Neutral → Overweight $16
Jul-19-21Resumed BTIG Research Buy $15
May-27-21Initiated Needham Hold
May-21-21Initiated UBS Buy $16
Apr-14-21Upgrade Cantor Fitzgerald Neutral → Overweight $17
Mar-26-24 09:53AM
Mar-20-24 07:00AM
Mar-13-24 07:07AM
Mar-06-24 11:56PM
Mar-05-24 01:50PM
07:00AM Loading…
Mar-01-24 07:00AM
Feb-29-24 11:25AM
11:23AM
Feb-28-24 11:49PM
08:20AM
07:32AM
07:00AM
Feb-15-24 07:00AM
Feb-09-24 03:14PM
Feb-08-24 07:00AM
07:00AM Loading…
Feb-01-24 07:00AM
Jan-12-24 11:02PM
09:31AM
Jan-08-24 09:40AM
Jan-07-24 04:00PM
Jan-05-24 07:02PM
Jan-03-24 11:46AM
07:00AM
Dec-30-23 09:01AM
Dec-29-23 09:48AM
07:01AM
Dec-24-23 06:17AM
Dec-21-23 05:01AM
Dec-08-23 11:30AM
Dec-05-23 06:38AM
06:00AM Loading…
06:00AM
05:30AM
Nov-15-23 09:48AM
Nov-10-23 10:07AM
Nov-09-23 01:02PM
Nov-08-23 07:13AM
07:00AM
Nov-04-23 05:03AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
07:00AM
Oct-27-23 07:00AM
Oct-08-23 07:00AM
Oct-05-23 07:45PM
03:01AM
Oct-03-23 07:00AM
Oct-02-23 08:20AM
Oct-01-23 08:30PM
Sep-29-23 12:22PM
09:09AM
Sep-28-23 11:08AM
10:50AM
10:41AM
10:32AM
Sep-21-23 08:42AM
Sep-07-23 11:30AM
Sep-01-23 07:00AM
Aug-29-23 07:00AM
Aug-21-23 07:00AM
Aug-15-23 07:00AM
Aug-09-23 09:25AM
Aug-08-23 08:40AM
07:29AM
07:00AM
Aug-07-23 08:48AM
Aug-04-23 08:05AM
Jul-31-23 07:00AM
Jul-23-23 10:23AM
Jul-20-23 02:24PM
Jul-17-23 01:54PM
Jun-28-23 10:53AM
Jun-27-23 07:00AM
Jun-09-23 11:30AM
Jun-04-23 09:59AM
May-11-23 07:44AM
May-10-23 08:15AM
07:10AM
07:00AM
May-08-23 10:00AM
May-02-23 07:00AM
May-01-23 10:01AM
07:00AM
Apr-26-23 01:00PM
Apr-18-23 09:20AM
Apr-14-23 02:45PM
Mar-31-23 11:30AM
Mar-27-23 07:00AM
Mar-08-23 07:00AM
Mar-02-23 11:39AM
04:28AM
Mar-01-23 09:35AM
07:00AM
Feb-27-23 07:00AM
Feb-22-23 05:00PM
Feb-14-23 07:00AM
Feb-13-23 07:00AM
Feb-12-23 07:33AM
Feb-08-23 07:00AM
Feb-01-23 09:43AM
Jan-09-23 07:00AM
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SBLENDORIO GLENNDirectorMar 07 '24Option Exercise2.8015,00042,00083,596Mar 11 05:36 PM
RAAB MICHAELDirectorMar 05 '24Option Exercise2.8015,00042,00083,596Mar 06 05:22 PM
MCGLYNN MARGARET GDirectorMar 05 '24Option Exercise2.807,50021,00066,789Mar 06 05:21 PM
MCGLYNN MARGARET GDirectorMar 05 '24Sale13.407,500100,50059,289Mar 06 05:21 PM
MCGLYNN MARGARET GDirectorMar 04 '24Option Exercise2.807,50021,00066,789Mar 06 05:21 PM
MCGLYNN MARGARET GDirectorMar 04 '24Sale13.297,50099,67559,289Mar 06 05:21 PM
Campbell Bradley LPresident and CEOMar 01 '24Option Exercise10.5415,833166,904887,052Mar 05 05:14 PM
Crowley John FExecutive ChairmanMar 01 '24Sale13.3529,181389,543573,478Mar 05 05:14 PM
Campbell Bradley LPresident and CEOMar 01 '24Sale13.1415,833208,017871,219Mar 05 05:14 PM
Crowley John FExecutive ChairmanFeb 15 '24Sale13.8131,614436,551697,628Feb 20 05:23 PM
Clark David MichaelChief People OfficerFeb 15 '24Sale14.004,42761,978253,664Feb 20 05:20 PM
Campbell Bradley LPresident and CEOFeb 15 '24Sale14.004,16758,338871,219Feb 20 05:21 PM
Rosenberg EllenChief Legal OfficerFeb 07 '24Option Exercise5.1629,600152,736397,254Feb 08 04:40 PM
Rosenberg EllenChief Legal OfficerFeb 07 '24Sale13.0029,600384,818367,654Feb 08 04:40 PM
Rosenberg EllenChief Legal OfficerFeb 06 '24Option Exercise5.164002,064368,054Feb 08 04:40 PM
Rosenberg EllenChief Legal OfficerFeb 06 '24Sale13.004005,200367,654Feb 08 04:40 PM
Campbell Bradley LPresident and CEOFeb 01 '24Option Exercise10.5415,833166,904891,219Feb 05 07:22 PM
Crowley John FExecutive ChairmanFeb 01 '24Sale12.6231,614398,918750,838Feb 05 07:22 PM
Campbell Bradley LPresident and CEOFeb 01 '24Sale12.5615,833198,858875,386Feb 05 07:22 PM
Crowley John FExecutive ChairmanJan 22 '24Sale12.3655,327683,958782,452Jan 24 05:20 PM
Crowley John FExecutive ChairmanJan 16 '24Sale12.7831,614404,106837,779Jan 18 05:09 PM
Crowley John FExecutive ChairmanJan 10 '24Sale13.6531,614431,452869,393Jan 11 06:33 PM
Clark David MichaelChief People OfficerJan 09 '24Sale14.001,38419,376266,705Jan 09 06:08 PM
Prout SamanthaChief Accounting OfficerJan 09 '24Sale14.001,33718,71880,953Jan 09 06:07 PM
Prout SamanthaChief Accounting OfficerJan 08 '24Sale14.0030,767430,82782,290Jan 09 06:07 PM
Clark David MichaelChief People OfficerJan 08 '24Sale14.008,726122,164268,089Jan 09 06:08 PM
Campbell Bradley LPresident and CEOJan 02 '24Option Exercise10.5415,833166,904956,138Jan 04 06:35 PM
Rosenberg EllenChief Legal OfficerJan 02 '24Option Exercise5.1630,000154,800372,285Jan 04 06:24 PM
Rosenberg EllenChief Legal OfficerJan 02 '24Sale14.2130,000426,219342,285Jan 04 06:24 PM
Campbell Bradley LPresident and CEOJan 02 '24Sale14.2315,833225,380947,805Jan 04 06:35 PM
Castelli JeffChief Development OfficerDec 28 '23Sale14.5217,421252,902340,661Dec 29 05:18 PM
Rosenberg EllenChief Legal OfficerDec 27 '23Option Exercise5.165,00025,800347,285Dec 28 05:08 PM
Rosenberg EllenChief Legal OfficerDec 27 '23Sale14.075,00070,327342,285Dec 28 05:08 PM
Rosenberg EllenChief Legal OfficerDec 26 '23Option Exercise5.1630,000154,800372,285Dec 28 05:08 PM
Rosenberg EllenChief Legal OfficerDec 26 '23Sale14.0030,000420,084342,285Dec 28 05:08 PM
Prout SamanthaChief Accounting OfficerDec 26 '23Sale14.007,659107,228121,912Dec 28 05:09 PM
Castelli JeffChief Development OfficerDec 20 '23Sale13.101,65421,667358,082Dec 20 04:41 PM
Castelli JeffChief Development OfficerDec 19 '23Sale13.2517,500231,875359,736Dec 20 04:41 PM
Crowley John FExecutive ChairmanDec 15 '23Sale12.666,04376,516877,748Dec 19 05:55 PM
Campbell Bradley LPresident and CEODec 01 '23Option Exercise2.9411,70234,404803,863Dec 05 05:07 PM
Campbell Bradley LPresident and CEODec 01 '23Sale11.0811,702129,693792,161Dec 05 05:07 PM
Crowley John FExecutive ChairmanDec 01 '23Sale11.086,04366,956883,791Dec 05 05:03 PM
Crowley John FExecutive ChairmanNov 15 '23Sale10.846,04365,497889,834Nov 17 05:23 PM
Campbell Bradley LPresident and CEONov 01 '23Option Exercise2.9411,70034,398803,861Nov 03 07:38 PM
Campbell Bradley LPresident and CEONov 01 '23Sale10.9711,700128,391792,161Nov 03 07:38 PM
Crowley John FExecutive ChairmanNov 01 '23Sale10.976,04466,327895,877Nov 03 07:37 PM
Crowley John FExecutive ChairmanOct 16 '23Sale10.506,04463,449901,921Oct 18 07:57 PM
Campbell Bradley LPresident & CEOOct 02 '23Option Exercise2.9411,70034,398803,861Oct 04 06:57 PM
Campbell Bradley LPresident & CEOOct 02 '23Sale11.2411,700131,489792,161Oct 04 06:57 PM
Crowley John FExecutive ChairmanOct 02 '23Sale11.256,04467,967907,965Oct 04 06:58 PM
Crowley John FExecutive ChairmanSep 15 '23Sale13.066,04478,964914,009Sep 18 05:09 PM
Campbell Bradley LPresident & CEOSep 01 '23Option Exercise2.9411,70034,398810,254Sep 06 05:29 PM
Campbell Bradley LPresident & CEOSep 01 '23Sale12.9718,093234,648792,161Sep 06 05:29 PM
Crowley John FExecutive ChairmanSep 01 '23Sale12.986,04478,447920,053Sep 06 05:31 PM
Crowley John FExecutive ChairmanAug 15 '23Sale13.036,04478,734926,097Aug 16 05:33 PM
Prout SamanthaChief Accounting OfficerAug 09 '23Option Exercise11.0336,909407,116173,912Aug 11 05:28 PM
Prout SamanthaChief Accounting OfficerAug 09 '23Sale14.0136,909516,933137,003Aug 11 05:28 PM
Campbell Bradley LPresident & CEOAug 01 '23Option Exercise2.9411,70034,398818,554Aug 03 05:09 PM
Campbell Bradley LPresident & CEOAug 01 '23Sale13.3920,000267,874798,554Aug 03 05:09 PM
Crowley John FExecutive ChairmanAug 01 '23Sale13.356,04480,716932,141Aug 03 05:10 PM
Crowley John FExecutive ChairmanJul 17 '23Sale13.456,04481,263938,185Jul 19 05:45 PM
Campbell Bradley LPresident & CEOJul 13 '23Sale12.516,80085,091806,854Jul 14 05:06 PM
Campbell Bradley LPresident & CEOJul 12 '23Sale12.511,50018,759813,654Jul 14 05:06 PM
Campbell Bradley LPresident & CEOJul 03 '23Option Exercise2.9411,70034,398826,854Jul 06 06:25 PM
Campbell Bradley LPresident & CEOJul 03 '23Sale12.3111,700144,016815,154Jul 06 06:25 PM
Crowley John FExecutive ChairmanJul 03 '23Sale12.316,04474,406944,229Jul 06 06:26 PM
Crowley John FExecutive ChairmanJun 15 '23Sale13.046,04478,814950,273Jun 20 05:18 PM
Campbell Bradley LPresident & CEOJun 06 '23Sale12.508,300103,777815,154Jun 08 05:26 PM
Campbell Bradley LPresident & CEOJun 01 '23Option Exercise2.6411,70030,907835,154Jun 05 07:16 PM
Campbell Bradley LPresident & CEOJun 01 '23Sale11.3611,700132,942823,454Jun 05 07:16 PM
Crowley John FExecutive ChairmanJun 01 '23Sale11.366,04468,657956,317Jun 05 07:16 PM
SBLENDORIO GLENNDirectorMay 18 '23Option Exercise3.3215,00049,80086,719May 19 05:13 PM
Crowley John FExecutive ChairmanMay 15 '23Sale11.186,04467,577962,361May 17 06:20 PM
Campbell Bradley LPresident & CEOMay 01 '23Option Exercise2.4511,70028,665835,154May 03 04:31 PM
Campbell Bradley LPresident & CEOMay 01 '23Sale11.8011,700138,093823,454May 03 04:31 PM
Crowley John FExecutive ChairmanMay 01 '23Sale11.806,04471,335968,405May 03 04:35 PM
Crowley John FExecutive ChairmanApr 17 '23Sale11.666,04470,502974,449Apr 19 05:45 PM
Campbell Bradley LPresident & CEOApr 03 '23Option Exercise2.4511,70028,665835,154Apr 05 08:25 PM
Campbell Bradley LPresident & CEOApr 03 '23Sale11.2111,700131,207823,454Apr 05 08:25 PM
Crowley John FExecutive ChairmanApr 03 '23Sale11.226,04467,787980,493Apr 05 08:26 PM
Last Close
Mar 27 04:00PM ET
24.73
Dollar change
0.00
Percentage change
0.00
%
KEM KraneShares Dynamic Emerging Markets Strategy ETF daily Stock Chart
CategoryGlobal or ExUS Equities - Quant Strat Asset TypeEquities (Stocks) TagsEmerging Return% 1Y- Shs Outstand Perf Week-1.02%
SponsorKrane Shares ETF Type Tagsequity Return% 3Y- Total Holdings3 Perf Month1.94%
Fund Family Bond Type TagsETFs Return% 5Y- AUM3.71M Perf Quarter0.43%
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range22.82 - 25.73 Perf YTD-0.10%
Dividend TTM0.70 (2.84%) ESG Type Tags- Flows% 3M0.00% 52W High-3.89% Beta-
Dividend Ex-DateDec 27, 2023 Dividend Type Sector/Theme Flows% YTD0.00% 52W Low8.37% ATR (14)0.21
Expense0.49% Structure Type Region Flows% 1Y RSI (14)52.29 Volatility0.21% 0.25%
Option/ShortYes / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.00 Prev Close24.73
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.53K Price24.73
SMA20-0.16% SMA502.45% SMA2000.71% Trades Volume0 Change0.00%
KraneShares Dynamic Emerging Markets Strategy ETF seeks growth of capital. In order to achieve its investment objective, the fund is actively managed and seeks to mitigate downside risk while attempting to outperform broad emerging markets by dynamically adjusting its allocations between the Underlying ETFs and cash and cash equivalents. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in securities of issuers located in emerging markets, including other investments, such as investment companies, that provide investment exposure to such securities.
Last Close
Mar 28 10:30AM ET
1.81
Dollar change
+0.01
Percentage change
0.56
%
LL LL Flooring Holdings Inc daily Stock Chart
Index- P/E- EPS (ttm)-3.59 Insider Own14.25% Shs Outstand28.85M Perf Week0.56%
Market Cap55.82M Forward P/E4.89 EPS next Y0.37 Insider Trans0.00% Shs Float26.44M Perf Month-16.97%
Income-103.49M PEG- EPS next Q- Inst Own44.52% Short Float4.15% Perf Quarter-54.64%
Sales904.75M P/S0.06 EPS this Y108.64% Inst Trans-12.67% Short Ratio4.06 Perf Half Y-40.85%
Book/sh5.45 P/B0.33 EPS next Y19.35% ROA-17.31% Short Interest1.10M Perf Year-48.87%
Cash/sh0.28 P/C6.36 EPS next 5Y30.00% ROE-50.07% 52W Range1.61 - 5.52 Perf YTD-53.59%
Dividend Est.- P/FCF13.10 EPS past 5Y-13.55% ROI-30.44% 52W High-67.21% Beta1.88
Dividend TTM- Quick Ratio0.12 Sales past 5Y-3.20% Gross Margin34.81% 52W Low12.77% ATR (14)0.12
Dividend Ex-Date- Current Ratio1.54 EPS Y/Y TTM-746.53% Oper. Margin-9.77% RSI (14)37.03 Volatility5.93% 6.60%
Employees2100 Debt/Eq1.36 Sales Y/Y TTM-18.54% Profit Margin-11.44% Recom5.00 Target Price2.00
Option/ShortYes / Yes LT Debt/Eq1.16 EPS Q/Q-18.36% Payout- Rel Volume1.30 Prev Close1.80
Sales Surprise-0.34% EPS Surprise8.82% Sales Q/Q-19.74% EarningsMar 04 BMO Avg Volume270.59K Price1.81
SMA20-4.79% SMA50-18.87% SMA200-43.71% Trades Volume71,658 Change0.56%
Date Action Analyst Rating Change Price Target Change
Jul-13-23Downgrade Loop Capital Hold → Sell $3.25
Jan-12-21Downgrade Loop Capital Buy → Hold
Jul-14-20Upgrade Loop Capital Hold → Buy $11 → $18
Jan-21-20Downgrade Morgan Stanley Equal-Weight → Underweight $9 → $5
May-01-19Upgrade Raymond James Mkt Perform → Outperform $16
Mar-20-19Initiated Evercore ISI In-line $10
Jan-03-19Downgrade Loop Capital Buy → Hold
Oct-31-18Reiterated Wedbush Neutral $22 → $12
Oct-30-18Downgrade Oppenheimer Outperform → Perform
Oct-10-18Initiated Citigroup Neutral $15
Mar-05-24 09:36AM
Mar-01-24 04:05PM
Feb-26-24 06:45AM
Jan-29-24 06:30AM
Jan-18-24 01:41PM
09:25AM Loading…
Nov-17-23 09:25AM
Nov-14-23 07:45AM
Nov-13-23 04:43PM
Nov-08-23 06:00AM
Oct-25-23 06:45AM
Oct-12-23 04:40PM
02:25PM
09:00AM
08:00AM
Aug-17-23 04:10PM
05:00PM Loading…
Aug-14-23 05:00PM
Aug-11-23 04:05PM
Aug-09-23 06:00AM
Jul-26-23 06:45AM
Jul-13-23 09:43AM
Jul-06-23 04:15PM
Jun-26-23 06:15AM
Jun-13-23 04:56PM
May-30-23 05:00PM
May-08-23 06:00AM
Apr-24-23 06:45AM
Mar-29-23 07:40AM
Mar-12-23 08:23AM
Mar-02-23 09:57PM
05:35AM
06:00AM Loading…
Mar-01-23 06:00AM
Feb-15-23 06:45AM
Feb-08-23 12:13PM
Jan-19-23 06:10AM
Jan-12-23 04:15PM
Dec-13-22 06:08AM
06:00AM
Dec-02-22 07:37PM
Nov-17-22 07:00AM
Nov-16-22 06:45AM
Nov-12-22 07:52AM
Nov-08-22 07:01PM
Nov-02-22 12:03PM
11:58AM
06:00AM
Oct-19-22 06:45AM
Oct-17-22 12:38PM
Sep-26-22 10:00AM
Sep-01-22 08:00AM
Aug-26-22 07:35AM
Aug-22-22 04:05PM
Aug-03-22 08:44AM
07:15AM
06:00AM
Jul-20-22 06:45AM
Jun-24-22 06:38AM
Jun-22-22 09:48AM
06:00AM
Jun-02-22 06:45AM
Jun-01-22 10:11AM
May-12-22 06:00AM
May-10-22 06:11AM
May-04-22 11:40AM
07:25AM
06:00AM
Apr-20-22 06:45AM
Apr-19-22 09:51AM
Apr-04-22 06:45AM
Mar-17-22 09:30AM
Mar-05-22 07:47AM
Feb-23-22 07:15AM
07:00AM
06:00AM
Feb-09-22 06:45AM
Feb-07-22 08:24AM
Jan-15-22 08:26AM
Dec-23-21 01:00PM
Dec-14-21 06:28AM
Dec-10-21 06:00AM
Dec-01-21 06:47AM
Nov-09-21 08:49AM
06:33AM
05:00AM
Nov-08-21 08:03AM
Nov-03-21 01:00PM
11:02AM
07:15AM
06:15AM
06:00AM
Oct-27-21 03:03PM
Oct-20-21 06:45AM
Oct-14-21 09:23AM
Oct-13-21 10:30AM
Sep-29-21 05:50PM
Sep-22-21 05:50PM
Sep-21-21 10:12AM
Sep-16-21 05:50PM
11:12AM
Sep-15-21 06:28AM
Sep-09-21 05:50PM
LL Flooring Holdings, Inc. engages in the business of retailing hard and soft surface flooring, and hard and soft surface flooring enhancements and accessories. The firm also offers an extensive assortment of hard and soft surface flooring such as waterproof hybrid resilient, waterproof vinyl plank, solid and engineered hardwood, laminate, bamboo, tile, and cork with a wide range of flooring enhancements and accessories to complement. The company was founded by Thomas David Sullivan in 1994 and is headquartered in Richmond, VA.